Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saisei Hawaii is a regenerative medicine company and clinical facility based in Honolulu, Hawaii, specializing in autologous stem cell therapies. The company utilizes adipose-derived stem cells (ADSCs) to treat a variety of chronic conditions, including osteoarthritis, autoimmune diseases, and metabolic disorders. By integrating advanced Japanese cell-processing protocols, Saisei Hawaii provides personalized treatments aimed at enhancing the body's natural healing and regenerative capabilities. The clinic serves both local patients and international medical tourists seeking non-surgical alternatives for degenerative health issues. Their approach focuses on the safety and efficacy of minimally invasive cell-based interventions. The company is led by medical professionals with extensive experience in the field of regenerative biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saisei Hawaii.